Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JV Biotherapeutics
Philadelphia, Pennsylvania, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
JV Biotherapeutics is a preclinical-stage biotechnology company focused on developing novel biologics for the treatment of cancer cachexia and metabolic diseases. The company's primary research centers on the Growth Differentiation Factor 15 (GDF15) pathway, aiming to modulate its activity to address severe weight loss and muscle wasting in cancer patients. By leveraging expertise in protein engineering, JV Biotherapeutics is designing therapies that can either inhibit or mimic GDF15 signaling depending on the clinical indication. Their lead programs are currently undergoing optimization and early-stage validation to support future IND filings.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- Recombinant proteinPeptidesBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on JV Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JV Biotherapeutics.